Summary
Bryn Taylor is a Principal Scientist in computational chemistry with 11 years of experience translating molecular simulation, machine learning, and microbiome insights into drug discovery at Johnson & Johnson Innovative Medicine. With a PhD co-advised by Rob Knight and Rommie Amaro at UC San Diego, Bryn combines expertise in molecular dynamics, Markov state models, and drug–protein interaction modeling to tackle small-molecule therapeutics informed by big data. They have a track record of moving academic methods into industrial projects across Janssen and Amaro/ Knight labs, bridging mechanistic simulation and predictive ML for actionable leads. Based in La Jolla, Bryn also brings a rare cross-disciplinary perspective from microbiome research to small-molecule design, enabling novel hypotheses about host–microbe influences on drug response.
11 years of coding experience
6 years of employment as a software developer
University of California San Diego
Biomedical Sciences PhD, Biomedical Sciences PhD at University of California, San Diego - School of Medicine